Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases
Disease area: Pulmonary vascular diseases, Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
E. Collinge, R. Frognier (Bouge, Belgium). Interest of check-up before discontinuing anti thrombotic therapy after a first episod of pulmonary embolism. Eur Respir J 2013; 42: Suppl. 57, 3354

Member's Comments

No comment yet.

Related content which might interest you: Hemorrhagic complications of treatment in patients with pulmonary embolism Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Comparision of side effects between thrombolytic and anticoagulation therapy in patients with Pulmonary Embolism Source: Virtual Congress 2020 – Pulmonary embolism Year: 2020 Comparision of catheter-directed therapy with the systemic thrombolysis for the treatment of acute pulmonary embolism with right ventricular dysfunction Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Evolution of pulmonary blood volume under anticoagulant therapy after a first symptomatic pulmonary embolism Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Clinical conundrums in pulmonary embolism treatment Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease Year: 2012 Home treatment of pulmonary embolism Source: Virtual Congress 2021 – Pulmonary vascular diseases Year: 2021 Anticoagulant treatment for acute pulmonary embolism: a pathophysiology-based clinical approach Source: Eur Respir J 2015; 45: 1142-1149 Year: 2015 Symptom-related telephone monitoring and cardiopulmonary exercise testing in the pulmonary embolism follow-up for early detection of chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Outpatient treatment of pulmonary embolism Source: Breathe, 16 (3) 200069; 10.1183/20734735.0069-2020 Year: 2020 The outcome of anticoagulation alone therapy for patients with submassive pulmonary embolism Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism Year: 2019 Thrombolytic therapy in cases with massive pulmonary thromboembolism Source: Eur Respir J 2005; 26: Suppl. 49, 521s Year: 2005 Beyond the guidelines? Case review of thrombolysis for pulmonary embolism at a district general hospital Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism Year: 2013 Thrombolytic therapy in massive pulmonary thromboembolism Source: Eur Respir J 2002; 20: Suppl. 38, 237s Year: 2002 Bilateral chylothorax in a patient with chronic central vein thrombosis and chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura Year: 2014 Risk factors for recurrences in patients with idiopathic pulmonary embolism after withdrawal of long-term anticoagulation Source: Eur Respir J 2006; 28: Suppl. 50, 44s Year: 2006 Complications of anticoagulant therapy in patients with pulmonary thromboembolism Source: Eur Respir J 2007; 30: Suppl. 51, 604s Year: 2007 Pulmonary embolism: who should receive thrombolysis? Source: International Congress 2014 – Current controversies in the management of acute pulmonary embolism Year: 2014 Duration of anticoagulation after isolated pulmonary embolism Source: Eur Respir J 2016; 47:1429-1435 Year: 2016 Global fibrinolytic profile in patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension Year: 2015